Search results
Results from the WOW.Com Content Network
According to the Journal Citation Reports, Molecular Psychiatry had an impact factor of 9.6 in 2023, ranking it 6th among 156 journals in the category "Psychiatry", 6th among 273 journals in the category "Neuroscience", and 11th among 298 journals in the category "Biochemistry & Molecular Biology".
Orthomolecular psychiatry is the use of orthomolecular medicine for mental illness. Orthomolecular psychiatry has been rejected by evidence-based medicine and has been called quackery. Orthomolecular psychiatry has been rejected by evidence-based medicine and has been called quackery.
Licinio is the founding and current chief editor of three journals from Springer Nature, Molecular Psychiatry, [5] Translational Psychiatry, [6] and Discover Mental Health. [7] His area of scientific expertise is precision medicine with a focus on pharmacogenomics, [8] as well as the biology of depression, and he has edited books on both topics.
Biological psychiatry or biopsychiatry is an approach to psychiatry that aims to understand mental disorder in terms of the biological function of the nervous system.It is interdisciplinary in its approach and draws on sciences such as neuroscience, psychopharmacology, biochemistry, genetics, epigenetics and physiology to investigate the biological bases of behavior and psychopathology.
The Nestler laboratory's focus in neuropsychopharmacology and molecular neuroscience concentrates on forming a molecular approach to psychiatry and furthering the understanding of the molecular basis of both depression and drug addiction, using animal models to study the way drug use or stress affects the brain. [1]
Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time. Those medications, however, are not without their risks and side effects.
Dr. Herbert Kleber, a professor of psychiatry at Columbia University and director of the New York State Psychiatric Institute’s Division on Substance Abuse, argues that the robust black market is a sign that the benefit of the medication outweighs the risk. “There is no medication without risk. People die every year from aspirin.
In other words, the goal is to transform parts of psychiatry into a neuroscience-based discipline. [ 3 ] Recent advances in molecular biology allowed for the identification of hundreds of common and rare genetic variations that contribute to psychiatric disorders.